Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial

被引:13
|
作者
Pulewka, Kristin [1 ,8 ]
Wolff, Daniel [2 ]
Herzberg, Philipp Y. [3 ]
Greinix, Hildegard [4 ]
Heussner, Pia [5 ]
Mumm, Friederike H. A. [5 ]
von Harsdorf, Stephanie [6 ]
Rieger, Kathrin [7 ]
Hemmati, Philipp [7 ]
Hochhaus, Andreas [8 ]
Hilgendorf, Inken [8 ]
机构
[1] Univ Hosp Jena, Inst Psychosocial Med & Psychotherapy, Jena, Germany
[2] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany
[3] Helmut Schmidt Univ, Fed Armed Forces Hamburg, Personal Psychol & Psychol Assessment, Fac Humanities & Social Sci, Hamburg, Germany
[4] Med Univ Graz, Div Hematol, Dept Internal Med 1, Graz, Austria
[5] Ludwig Maximilians Univ Munchen, Dept Internal Med 3, Psychooncol, Klinikum Grosshadern, Munich, Germany
[6] Univ Ulm, Dept Internal Med 3, Ulm, Germany
[7] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[8] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Klinikum 1, D-07740 Jena, Germany
关键词
Adolescents and young adults (AYA); Stem-cell transplantation; Quality of life; Psycho-oncology; QUALITY-OF-LIFE; HUMAN ACTIVITY PROFILE; TERM-FOLLOW-UP; CANCER SURVIVORS; MARROW-TRANSPLANTATION; CARE; VALIDATION; DISTRESS; SUPPORT; INTERVENTIONS;
D O I
10.1007/s00432-017-2424-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Allogeneic hematopoietic stem-cell transplantation (alloHSCT) is physically and psychosocially demanding. Among transplant recipients, adolescent and young adults (AYA) represent a special group, as disease occurs early in life, resulting in the prospect of long survival time and high burden of alloHSCT sequelae. However, data focusing on AYA undergoing alloHSCT are rare. Methods Data resulting from a prospective multicenter trial initially focusing on graft-versus-host disease (GvHD) after alloHSCT were reused to analyse the differences between AYA and elderly patients. In total, data of 205 alloHSCT recipients were evaluated. Patients completed the FACTBMT, HAP, SF-36, 24-AM, LOT-R, BSSS, HADS, and GvHD questionnaires. Results Median age of AYA and non-AYA patients was 29 and 52 years. Using 24-AM-Test, evaluating personality traits, non-AYA reported to be more conscientious (p = 0.033). However, AYA described higher quality of life regarding physical role functioning (p = 0.001), physical functioning (p = 0.002), bodily pain (p = 0.023), and emotional role function (p = 0.027) in the SF-36. General health perception, vitality, social role functioning, and mental health were comparable among both groups. On HAP scale, AYA reported higher maximum (p = 0.003) and adjusted activity scores (p = 0.002), but showed similar restrictions regarding activity, self-supply, and self-determination. Conclusion AYA represent a particular group characterized by higher physical well-being and activity scores, and significantly vary from non-AYA patients in psychosocial aspects. Studies covering distinctive features of AYA undergoing alloHSCT are warranted to improve awareness of the special needs of this group.
引用
收藏
页码:1613 / 1619
页数:7
相关论文
共 50 条
  • [1] Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial
    Kristin Pulewka
    Daniel Wolff
    Philipp Y. Herzberg
    Hildegard Greinix
    Pia Heussner
    Friederike H. A. Mumm
    Stephanie von Harsdorf
    Kathrin Rieger
    Philipp Hemmati
    Andreas Hochhaus
    Inken Hilgendorf
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1613 - 1619
  • [2] Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation
    Kaffenberger, Benjamin H.
    Wong, Henry K.
    Jarjour, Wael
    Andritsos, Leslie A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (03) : 489 - 492
  • [3] Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study
    Haavisto, Anu
    Mathiesen, Sidsel
    Suominen, Anu
    Lahteenmaki, Paivi
    Sorensen, Kaspar
    Ifversen, Marianne
    Juul, Anders
    Nielsen, Malene Mejdahl
    Muller, Klaus
    Jahnukainen, Kirsi
    CANCERS, 2020, 12 (07) : 1 - 12
  • [4] Prospective Assessment of Bone Turnover and Clinical Bone Diseases After Allogeneic Hematopoietic Stem-Cell Transplantation
    Petropoulou, Anna D.
    Porcher, Raphael
    Herr, Andree-Laure
    Devergie, Agnes
    Brentano, Thomas Funck
    Ribaud, Patricia
    Pinto, Fernando O.
    Rocha, Vanderson
    de Latour, Regis Peffault
    Orcel, Philippe
    Socie, Gerard
    Robin, Marie
    TRANSPLANTATION, 2010, 89 (11) : 1354 - 1361
  • [5] Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial
    Jaspers, Aurelie
    Baron, Frederic
    Willems, Evelyne
    Seidel, Laurence
    Hafraoui, Kaoutar
    Vanstraelen, Gaetan
    Bonnet, Christophe
    Beguin, Yves
    BLOOD, 2014, 124 (01) : 33 - 41
  • [6] Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study
    Scherwath, Angela
    Schirmer, Lena
    Kruse, Margitta
    Ernst, Gundula
    Eder, Matthias
    Dinkel, Andreas
    Kunze, Sabine
    Balck, Friedrich
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Dolan, Karin
    Gramatzki, Martin
    Kolb, Hans-Jochem
    Heussner, Pia
    Wilhelm, Hans
    Beelen, Dietrich W.
    Schulz-Kindermann, Frank
    Zander, Axel R.
    Koch, Uwe
    Mehnert, Anja
    PSYCHO-ONCOLOGY, 2013, 22 (07) : 1509 - 1516
  • [7] Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial
    Knols, R. H.
    de Bruin, E. D.
    Uebelhart, D.
    Aufdemkampe, G.
    Schanz, U.
    Stenner-Liewen, F.
    Hitz, F.
    Taverna, C.
    Aaronson, N. K.
    BONE MARROW TRANSPLANTATION, 2011, 46 (09) : 1245 - 1255
  • [8] Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers
    Toenges, R.
    Greinix, H.
    Lawitschka, A.
    Halter, J.
    Baumgartner, A.
    Simon, A.
    Arends, J.
    Jaeger, P.
    Middeke, M.
    Hilgendorf, I.
    Klein, S.
    Wagner-Drouet, E. M.
    Schmid, C.
    Bug, G.
    Wolff, D.
    CLINICAL NUTRITION, 2021, 40 (04) : 1571 - 1577
  • [9] Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: Diagnosis and gender matter
    Schulte, CMS
    Beelen, DW
    TRANSPLANTATION, 2004, 78 (07) : 1055 - 1063
  • [10] Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I
    Suttorp, M.
    Claviez, A.
    Bader, P.
    Peters, C.
    Gadner, H.
    Ebell, W.
    Dilloo, D.
    Kremens, B.
    Kabisch, H.
    Fuehrer, M.
    Zintl, F.
    Goebel, U.
    Klingebiel, T.
    KLINISCHE PADIATRIE, 2009, 221 (06): : 351 - 357